Concepedia

Daniel A. Pollyea

DA

Statistics

Publications

142

Citations

22K

H-Index

64

Active since

2004

Affiliations

University of Colorado Denver(Current)

The University of Texas MD Anderson Cancer Center

Dana-Farber Cancer Institute

University of Colorado Anschutz Medical Campus

Memorial Sloan Kettering Cancer Center

Daniel A. Pollyea is an author at University of Colorado Denver specializing in medicine, oncology, and hematology.

ORCID

Top concepts

Publications per year

2004–2024

142

Publications

142

Venetoclax combined with decitabine or azacitidine in treatment-naive, elderly patients with acute myeloid leukemia

Courtney D. DiNardo, Keith W. Pratz, Vinod Pullarkat et al. · Blood · 2018 · 1.8K citations · Full text

Enasidenib in mutant IDH2 relapsed or refractory acute myeloid leukemia

Eytan M. Stein, Courtney D. DiNardo, Daniel A. Pollyea et al. · Blood · 2017 · 1.4K citations · Full text

Functional genomic landscape of acute myeloid leukaemia

Jeffrey Tyner, Cristina E. Tognon, Daniel Bottomly et al. · Nature · 2018 · 1.4K citations · Full text

, , +7

Durable Remissions with Ivosidenib in <i>IDH1</i> -Mutated Relapsed or Refractory AML

Courtney D. DiNardo, Eytan M. Stein, Stéphane de Botton et al. · New England Journal of Medicine · 2018 · 1.4K citations · Full text

Efficacy and Biological Correlates of Response in a Phase II Study of Venetoclax Monotherapy in Patients with Acute Myelogenous Leukemia

Marina Konopleva, Daniel A. Pollyea, Jalaja Potluri et al. · Cancer Discovery · 2016 · 1K citations · Full text

Rows per page

1–5 of 142